Kevin Lynch is the founder of Antengene Corporation. Antengene Corporation has raised $141M in total funding. Latest round: Series B.
Kevin Lynch was appointed as the Chief Medical Officer (CMO) of Antengene Corporation in March 2021. He brings nearly 30 years of experience in pharmaceutical R&D, having held national, regional, and global clinical roles at companies like Novartis and Celgene.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide